KaloBios Files for Chapter 11 Bankruptcy - New York Times

KaloBios Files for Chapter 11 Bankruptcy
New York Times
KaloBios Pharmaceuticals, the troubled California biotechnology company that ousted Martin Shkreli this month, filed for Chapter 11 bankruptcy on Tuesday. The drug maker listed roughly $8.4 million in assets and close to $2 million in debt in filings ...
KaloBios Pharmaceuticals, Inc. Files For Chapter 11 Bankruptcy ProtectionPR Newswire (press release)
Martin Shkreli-Linked KaloBios Enters Chapter 11Wall Street Journal (blog)
KaloBios Files for Chapter 11 Bankruptcy ProtectionGenetic Engineering & Biotechnology News (press release)
StreetInsider.com -Benzinga -Reuters
all 406 news articles »